BioSpace News Archive

Developed by Research Institute of Brain Activation and the Tokyo Metropolitan Institute of Technology, Brain Assessment is an online cognitive function test for healthy individuals that compares the average rate of cognitive decline with aging.

The global drug of abuse testing market size is predicted to reach over US$ 9.43 billion by 2028 from valued at US$ 6.14 billion in 2021, growing at a CAGR of 6.4% from 2021 to 2030.

The enteral feeding devices market size is predicted to reach over US$ 4.72 billion by 2028 from USD 3.16 billion in 2021 and growing at a CAGR of 5.9% from 2022 to 2030.

Exagen Inc., a leading provider of autoimmune testing solutions, announced the formation of its new Scientific Advisory Board with appointment of seven doctors and rheumatology experts.

Albany NY, United States: Transparency Market Research has published a new report titled, “Tissue Banking Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.

New Agreement with Federal Equipment Company Expands Companies Capabilities.

Zymergen Inc. announced it will report preliminary financial results for the fourth quarter and full year 2021 after market close on Tuesday, March 22nd, 2022.

Avid Bioservices, Inc., a dedicated biologics contract development and manufacturing organization working to improve patient lives by providing high quality services to biotechnology and pharmaceutical companies, announced that the company will participate in the KeyBanc Capital Markets Life Sciences & MedTech Forum.

C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science to develop a new generation of small-molecule medicines and transform how disease is treated, announced the appointment of Utpal Koppikar, MBA, to its board of directors.